The AHR agonist ITE mitigates cardiomyocyte apoptosis by activating the Akt/p70S6K signaling pathway, thereby attenuating left ventricular remodeling and improving cardiac dysfunction following myocardial infarction (Lin et al. 2023). The gene discussed is RPS6KB1; the disease is myocardial infarction.